Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date. - Hanley,B; Roufosse,CA; Osborn,M; Naresh,KN (British Journal of Haematology, 2020)